(Q35953677)

11 August 2017

1 reference

title

Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension (English)

1 reference

11 August 2017

P. Chrisp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1554974

8 October 2022

E. M. Sorkin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1554974

8 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1554974

8 October 2022

publication date

1 January 1992

1 reference

11 August 2017

1 reference

11 August 2017

2

1 reference

11 August 2017

1

1 reference

11 August 2017

58-77

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199202010-00007

11 August 2017

0 references

cites work

Early visual field changes with beta-blocking agents

1 reference

12 December 2020

A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure

1 reference

12 December 2020

A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure.

1 reference

12 December 2020

[Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)]

1 reference

12 December 2020

Systemic drug interactions with topical glaucoma medications

1 reference

12 December 2020

The 12-hour control of intraocular pressure on carteolol 2% twice daily

1 reference

12 December 2020

[Intraocular penetration of 14C-Carteolol hydrochloride (beta-blocker) in the albino rabbits]

1 reference

12 December 2020

[Effects of pilocarpine and carteolol, a new beta-adrenergic blocking agent on human aqueous humor dynamics (author's transl)]

1 reference

12 December 2020

Topical timolol decreases plasma high-density lipoprotein cholesterol level.

1 reference

12 December 2020

1 reference

12 December 2020

Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma

1 reference

12 December 2020

Ocular hypotensive effect of 8-hydroxycarteolol, a metabolite of carteolol

1 reference

12 December 2020

Systemic complications of beta-blocking eyedrops. Apropos of 6 cases

1 reference

12 December 2020

Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers

1 reference

12 December 2020

Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis.

1 reference

12 December 2020

[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions]

1 reference

12 December 2020

[Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma]

1 reference

12 December 2020

Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent

1 reference

12 December 2020

Measuring drug-induced eye irritation: a simple new clinical assay

1 reference

12 December 2020

[Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops]

1 reference

12 December 2020

Pharmacologic effects of beta-blocking agents used in the management of glaucoma

1 reference

12 December 2020

The effect of long-term topical administration of commercial beta-blockers on the rat corneal endothelium

1 reference

12 December 2020

Effect of different antiglaucomatous drugs on ocular perfusion pressures

1 reference

12 December 2020

[Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics]

1 reference

12 December 2020

Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol

1 reference

12 December 2020

[Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)]

1 reference

12 December 2020

Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man

1 reference

12 December 2020

Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs

1 reference

12 December 2020

Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism

1 reference

12 December 2020

Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient

1 reference

12 December 2020

[Effect of topical 8-hydroxy carteolol on intraocular pressure and melanin granules]

1 reference

12 December 2020

1% carteolol hydrochloride eyedrops: long-term experience in the treatment of chronic open-angle glaucoma

1 reference

12 December 2020

[Effect of carteolol and timolol eyedrops on the pressure tolerance of the optic nerve head]

1 reference

12 December 2020

1 reference

12 December 2020

Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension

1 reference

12 December 2020

A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.

1 reference

12 December 2020

Systemic effects of medications used to treat glaucoma

1 reference

12 December 2020

New developments in the drug treatment of glaucoma

1 reference

12 December 2020

[Human pharmacology of carteolol]

1 reference

12 December 2020

Pharmacokinetics of carteolol in relation to renal function

1 reference

12 December 2020

A double-masked comparison of carteolol and timolol in ocular hypertension

1 reference

12 December 2020

Ocular levobunolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition

1 reference

12 December 2020

[Effect of beta receptor blockers on the pressure tolerance of the optic nerve head]

1 reference

12 December 2020

Pharmacokinetics and absolute bioavailability of carteolol, a new ?-adrenergic receptor blocking agent

1 reference

12 December 2020

Effects of three beta-blocker eye drops on the rabbit cornea: an electron microscope study

1 reference

12 December 2020

Evaluation of ocular toxicity of two beta blocking drugs, carteolol and practolol, in beagle dogs

1 reference

12 December 2020

[Animal experimental studies on the pharmacokinetics of carteolol]

1 reference

12 December 2020

A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea

1 reference

12 December 2020

Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension

1 reference

12 December 2020

Glaucoma: detection before damage, fewer side effects may be possible

1 reference

12 December 2020

Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study.

1 reference

12 December 2020

A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma

1 reference

12 December 2020

Comparison of ophthalmic beta-blocking agents

1 reference

12 December 2020

Concentration-effect and time-effect relationships of carteolol

1 reference

12 December 2020

The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities

1 reference

12 December 2020

The Relevance of Intrinsic Sympathomimetic Activity for β-Blocker-Induced Changes in Plasma Lipids

1 reference

12 December 2020

Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension

1 reference

12 December 2020

Carteolol: Preliminary Study on Ocular Pressure-Reducing Action

1 reference

12 December 2020

10.2165/00002512-199202010-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference